Table 2 Relationship between PRDM5 expression and clinicopathological characteristics in Validation Data Set
From: Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
PRDM5 LOW | PRDM5 HIGH | P-value | |
|---|---|---|---|
Patient characteristics | N = 178 | N = 77 | |
Sex | 0.177 | ||
 female | 54 | 17 | |
 male | 124 | 60 | |
Age | 0.496 | ||
 ≧60 | 134 | 61 | |
 <  60 | 44 | 16 | |
T stage | 0.012 | ||
 I-II | 67 | 35 | |
 III-IV | 111 | 42 | |
N stage | 0.061 | ||
 N0 | 93 | 50 | |
 YES | 85 | 27 | |
M stage | 0.540 | ||
 N0 | 177 | 76 | |
 YES | 1 | 1 | |
TNM stage | 0.013 | ||
 I-II | 95 | 54 | |
 III-IV | 83 | 23 | |
Histological grade | 0.030 | ||
 Well | 19 | 14 | |
 Moderately | 89 | 45 | |
 Poorly | 70 | 18 | |
Nerve invasion | 0.232 | ||
 N0 | 167 | 75 | |
 YES | 11 | 2 | |
Vascular invasion | 0.045 | ||
 N0 | 147 | 71 | |
 YES | 31 | 6 |